Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Aanesthetic Agents for Day Surgery - NIHR Health Technology ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
90<br />
Conclusions<br />
Many adults and parents of children wish to avoid<br />
an inhalational induction. However, after receiving<br />
an inhalational induction, two-thirds of patients<br />
would be happy to receive one again.<br />
When selecting and recommending a technique<br />
<strong>for</strong> a day patient, the anaesthetist should bear the<br />
following outcomes in mind:<br />
• In both adults and children a sevoflurane/<br />
sevoflurane anaesthetic regimen is associated<br />
with a higher incidence of PONV than a<br />
regimen incorporating propofol. In children,<br />
sevoflurane/sevoflurane is also associated<br />
with agitation in recovery.<br />
• In children a sevoflurane/sevoflurane regimen<br />
is more expensive than propofol/halothane<br />
or the modelled cost of propofol/isoflurane.<br />
However, the value parents place on their child<br />
receiving an inhalational induction balances<br />
out the additional cost.<br />
• A propofol-containing regimen appears to<br />
confer anti-emetic protection. The additional<br />
anti-emetic benefit conferred by TIVA, as<br />
opposed to propofol/volatile agent, is not<br />
statistically significant. PONV aside, clinicians<br />
may also select TIVA <strong>for</strong> its ‘volatile-free’<br />
environment.<br />
Implications <strong>for</strong> future research<br />
The CESA project identified a number of<br />
areas where further research is needed. Specific<br />
anaesthetic-related issues requiring further work<br />
are discussed below. A concern more general<br />
to the remainder of healthcare that has been<br />
highlighted by this study is the role of patients’<br />
preferences in decision-making and implications<br />
<strong>for</strong> further research in this area are also<br />
explored below.<br />
Use of opioid analgesics<br />
The national practice survey indicated that<br />
analgesia is provided by intraoperative opioids in<br />
60–70% of adults, with a relatively small number<br />
receiving NSAIDs either pre- or intraoperatively.<br />
The high usage of opioids, with almost half of all<br />
patients receiving fentanyl, is perhaps surprising,<br />
given their association with nausea and vomiting.<br />
The use of NSAIDs <strong>for</strong> perioperative analgesia<br />
may, in practice, be higher than the survey<br />
suggests, <strong>for</strong> two reasons. First, the survey did<br />
not ask about the administration of postoperative<br />
analgesics, and these agents may be widely used<br />
in the postoperative period. Second, the survey<br />
instrument asked the respondent to identify just<br />
one intraoperative analgesic. Respondents may<br />
have recorded opioid usage in preference to a<br />
concurrent usage of NSAIDs.<br />
The use of these analgesics could affect the<br />
clinical effectiveness and costs of and patient<br />
preferences <strong>for</strong> different anaesthetic regimens.<br />
This is a question that was not investigated in<br />
the CESA RCT, and further work may clarify the<br />
impact of opioid use on patient outcome after<br />
day surgery. Observational studies may prove<br />
the most useful method <strong>for</strong> identification of<br />
practice patterns.<br />
Use of prophylactic anti-emetics<br />
A distinction was made between prophylactic antiemetics<br />
and those given <strong>for</strong> treatment of nausea<br />
or vomiting. Around half the respondents do<br />
not give routine anti-emetic prophylaxis to adult<br />
patients, while 30–40% always use prophylaxis,<br />
with ondansetron and cyclizine being the most<br />
popular agents. The use of prophylactic antiemetics<br />
was lower in paediatric patients. Despite<br />
the prohibition of prophylactic anti-emetics, the<br />
overall incidence of nausea and vomiting in the<br />
CESA RCT was low. This may be because the<br />
protocol precluded the use of intraoperative<br />
morphine, although small numbers of patients<br />
received other short-acting opioids. This<br />
raises questions around the necessity <strong>for</strong> the<br />
widespread use of prophylactic anti-emetics<br />
revealed in the national survey. Systematic<br />
review of the literature around the use of<br />
these agents in day surgery may help to<br />
answer these questions.<br />
Risks associated with PONV<br />
The CESA RCT <strong>for</strong> adults found that an increased<br />
risk of PONV was associated with gender, with<br />
women of childbearing age being more at risk,<br />
whether undergoing gynaecological or general<br />
surgery. Higher risk was also associated with a<br />
longer anaesthetic duration, and with agitation<br />
in the recovery area. It was not within the scope<br />
of the trial to determine whether this agitation<br />
was a cause or a consequence of feeling nauseated<br />
or vomiting. Similar results have been reported<br />
in other evaluations. However, further research<br />
is required to explore the potential causes and<br />
management implications of these events, such<br />
as the clinical and economic impact of risk<br />
assessment of patients.<br />
Other combinations of anaesthetics<br />
The CESA RCT was not able to compare all<br />
possible combinations of anaesthetic regimens<br />
and treatment protocols currently used in routine